CD177 and neoplasm: When MC38/Nb1 tumors were grown in CD8 T cell-depleted mice, tumor growth significantly increased and became indistinguishable from MC38/BCII10 control tumors, illustrating that anti-NRP-1 Nbs unleashed an efficient anti-tumor CTL response.